ER and progesterone receptor (PR) proteins did correlate with Tamoxifen sensitivity, but interestingly, this was not one of the stronger correlations observed (perhaps due in part to the relative underrepresentation of ER+ versus ER− breast cancer cell lines). The gene discussed is PGR; the disease is breast carcinoma.